Medicine Grand Rounds with NYU's Dr. Daniel Sterman

The Department of Medicine at the University of Arizona College of Medicine – Tucson presents:

Topic: “The future of Interventional Pulmonology: Will intratumoral thereapy replace lung cancer resection?”
Daniel Sterman, MD

Noon-1 p.m., Lecture Hall, Room 5403
College of Medicine – Tucson
(See flyer below for ALL virtual viewing links.)

— A light lunch will be provided. —

LIVESTREAM LINK!

Presenter: Daniel H. Sterman, MD, is the Thomas and Suzanne Murphy Professor of Pulmonary and Critical Care Medicine in the Departments of Medicine and Cardiothoracic Surgery at the New York University Grossman School of Medicine; director of the Division of Pulmonary, Critical Care, and Sleep Medicine; and director of the Multidisciplinary Pulmonary Oncology Program at NYU Langone Health in New York City. He was previously lead clinical investigator in the multidisciplinary Thoracic Oncology Research Group at the Perelman School of Medicine at the University of Pennsylvania and the principal investigator of the Clinical Trials Project for the Penn NCI Thoracic Oncology Program Project Grant (1997-2015).

Dr. Sterman’s research interests are related to the treatment of thoracic malignancies, specifically as they apply to the synergy of molecular medicine, tumor immunotherapy and novel technologies in interventional pulmonology. Over the past 25 years, he has focused on the translation of laboratory discoveries from the bench to the bedside: conducting multiple human clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma, and other pleural malignancies. He has served as principal investigator of multiple clinical trials of intra-pleural gene delivery in patients with pleural malignancies and is considered an international expert in this emerging field.

As director of the NYU PORT (Pulmonary Oncology Research Team), Dr. Sterman has expanded his research interests into further development of local intra-tumoral and intra-nodal immunotherapies. He is currently co-national PI of the LuTK02 clinical trial, which is investigating intra-tumoral adenoviral-mediated HSV thymidine kinase gene delivery in patients with advanced non-small cell lung cancer refractory to immune checkpoint inhibition, as well as the global principal investigator of the INFINITE clinical trial, a randomized Phase III clinical trial of intra-pleural adenovirus-interferon alpha 2b gene transfer in combination with chemotherapy as second/third line therapy for pleural mesothelioma. In addition, he has developed an NIH/NCI funded clinical trial program of bronchoscopic cryo-immunotherapy for treatment of non-small cell lung cancer.

READ MORE

■ Flyer for this event: 

Department of Medicine Grand Rounds

Medicine Grand Rounds are held in Room 5403, on the fifth floor of the College of Medicine – Tucson. To view Medicine Grand Rounds remotely, see this live weblink: https://streaming.biocom.arizona.edu/streaming/. To view it after the fact, click on "Archive" at the top of this same link's webpage and, from the dropdown menu under "Category," select "Medicine Grand Rounds" and click "Search" to find the event you're seeking.

Accreditation Statement: The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with ineligible companies that would constitute a conflict of interest concerning this CME activity.

Learning Objectives:

• Diagnose a variety of internal medicine illnesses
• Understand more clearly advances in therapy
• Become truly professional physicians

For questions or accommodations that may be necessary, please contact the Office of the Chair, 520-626-6349 at least three days in advance of event.